| |SEPTEMBER 202619C O V E R S T O R Y .....FINISHED PELLETS FORMULATIONS MANUFACTURER FOR THE YEAR - 2026TOPPelcoatStrengthening Drug Delivery through Specialized Pellet FormulationsThe pharmaceutical industry's growing emphasis on controlled drug release, formulation precision and patient-centric therapies is strengthening the relevance of finished pellet formulations. Multiparticulate systems offer pharmaceutical companies greater flexibility in designing immediate, sustained and modified-release products while enabling more controlled drug-release profiles. As regulatory expectations rise alongside demand for specialized dosage forms, manufacturers need to combine formulation science with consistent quality, scalable production and dependable delivery.Positioned within this specialized segment is Pelcoat, a pharmaceutical formulation company that has developed considerable depth in finished pellets, particularly sustained- and modified-release formulations. From approximately 30 products at the beginning of its journey to around 300 today, the company has expanded through focused R&D, manufacturing investments and disciplined product development. With around 40 licensed sustained-release products and approvals from several prominent pharmaceutical companies, Pelcoat is building its position around three fundamentals: quality, cost effectiveness and timely delivery.By Deepshikha
< Page 9 | Page 11 >